The KEGG pathway enrichment results revealed that the putative targets were significantly enriched in hepatitis B and viral carcinogenesis, and the cAMP signaling pathway, PI3K-Akt signaling route, MAPK signaling pathway, estrogen signaling pathway, p53 signaling pathway, and cell cycle signaling pathway were all found to be enriched in cancer pathways. The gene discussed is AKT1; the disease is hepatitis B virus infection.